The IPO Buzz: Eikon Therapeutics (EIKN) Upsizes IPO & Prices it at $18 – High End
Eikon Therapeutics (EIKN) upsized its IPO at pricing to 21.18 million shares – up from 17.65 million shares in the prospectus – and priced the IPO at $18.00 – the high end of its range – to raise $381.24 million on Wednesday night, Feb. 4, 2026. At pricing, Eikon Therapeutics had a market cap of […]
February 4, 2026 Read More